Grant Grady III

Grant Grady III is listed in filings as Director at Aptevo Therapeutics Inc.. This profile follows SEC Form 4 activity through Nov 12, 2025, including purchase activity. Recent filings connect the profile to Aptevo Therapeutics Inc. (APVO). The current snapshot covers public activity from Jul 19, 2024 to Nov 12, 2025. Reported amounts are shown as $20.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.